The firm shows a Beta (market volatility) of 0.0, which signifies not very significant fluctuations relative to the market. the returns on MARKET and Bloomios are completely uncorrelated.
Risk-Adjusted Performance
Weakest
Weak
Strong
Over the last 90 days Bloomios has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable primary indicators, Bloomios is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors. ...more
Begin Period Cash Flow
72.2 K
Total Cashflows From Investing Activities
-798.3 K
Bloomios
Bloomios Relative Risk vs. Return Landscape
If you would invest 0.01 in Bloomios on September 27, 2025 and sell it today you would earn a total of 0.00 from holding Bloomios or generate 0.0% return on investment over 90 days. Bloomios is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of pink sheets are less volatile than Bloomios, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
Expected Return
Risk
Bloomios Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Bloomios' investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Bloomios, and traders can use it to determine the average amount a Bloomios' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
Best Portfolio
Best Equity
Good Returns
Average Returns
Small Returns
Cash
Small Risk
Average Risk
High Risk
Huge Risk
BLMS
Based on monthly moving average Bloomios is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Bloomios by adding Bloomios to a well-diversified portfolio.
Bloomios Fundamentals Growth
Bloomios Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Bloomios, and Bloomios fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Bloomios Pink Sheet performance.
Assessing Bloomios' fundamental ratios provides investors with valuable insights into Bloomios' financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Bloomios is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Bloomios, Inc. manufactures, markets, and distributes cannabidiol products. Bloomios, Inc. was incorporated in 2001 and is headquartered in Santa Barbara, California. Bloomios is traded on OTC Exchange in the United States.
Things to note about Bloomios performance evaluation
Checking the ongoing alerts about Bloomios for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Bloomios help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Bloomios generated a negative expected return over the last 90 days
Bloomios has some characteristics of a very speculative penny stock
Bloomios currently holds 150 K in liabilities. Bloomios has a current ratio of 0.09, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Bloomios until it has trouble settling it off, either with new capital or with free cash flow. So, Bloomios' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Bloomios sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Bloomios to invest in growth at high rates of return. When we think about Bloomios' use of debt, we should always consider it together with cash and equity.
The entity reported the previous year's revenue of 8.49 M. Net Loss for the year was (2.01 M) with profit before overhead, payroll, taxes, and interest of 3.78 M.
Bloomios currently holds about 64 K in cash with (98.52 K) of positive cash flow from operations.
Roughly 80.0% of the company shares are held by company insiders
Evaluating Bloomios' performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Bloomios' pink sheet performance include:
Analyzing Bloomios' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Bloomios' stock is overvalued or undervalued compared to its peers.
Examining Bloomios' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
Evaluating Bloomios' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Bloomios' management team can help you assess the Company's leadership.
Pay attention to analyst opinions and ratings of Bloomios' pink sheet. These opinions can provide insight into Bloomios' potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Bloomios' pink sheet performance is not an exact science, and many factors can impact Bloomios' pink sheet market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.
Additional Tools for Bloomios Pink Sheet Analysis
When running Bloomios' price analysis, check to measure Bloomios' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bloomios is operating at the current time. Most of Bloomios' value examination focuses on studying past and present price action to predict the probability of Bloomios' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bloomios' price. Additionally, you may evaluate how the addition of Bloomios to your portfolios can decrease your overall portfolio volatility.